nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abortion access and the US medical workforce: a looming crisis for haematology
|
Marshall, Ariela L |
|
|
9 |
12 |
p. e874-e875 |
artikel |
2 |
Acquired haemophilia in an Edo period Japanese surgical casebook
|
Fan, Bingwen Eugene |
|
|
9 |
12 |
p. e876-e877 |
artikel |
3 |
Blinatumomab plus hyper-CVAD: the prelude to a new era in acute lymphocytic leukaemia
|
León, Andrés Gómez-De |
|
|
9 |
12 |
p. e864-e865 |
artikel |
4 |
CAR T-cell therapies in China: rapid evolution and a bright future
|
Hu, Yongxian |
|
|
9 |
12 |
p. e930-e941 |
artikel |
5 |
COP27 Climate Change Conference: urgent action needed for Africa and the world
|
Atwoli, Lukoye |
|
|
9 |
12 |
p. e871-e873 |
artikel |
6 |
Gene therapy in China: past, present, and future
|
Zhang, Lei |
|
|
9 |
12 |
p. e869-e871 |
artikel |
7 |
Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions
|
Chang, Ying-Jun |
|
|
9 |
12 |
p. e919-e929 |
artikel |
8 |
Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b–2, open-label study
|
Martin, Thomas |
|
|
9 |
12 |
p. e897-e905 |
artikel |
9 |
Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial
|
Jabbour, Elias |
|
|
9 |
12 |
p. e878-e885 |
artikel |
10 |
Increasing availability of oral therapy in haematology
|
The Lancet Haematology, |
|
|
9 |
12 |
p. e863 |
artikel |
11 |
Lenalidomide and risk of second primary malignancy—is disease context key?
|
Pawlyn, Charlotte |
|
|
9 |
12 |
p. e868-e869 |
artikel |
12 |
Lower strength stockings: is less better?
|
ten Cate-Hoek, Arina J |
|
|
9 |
12 |
p. e865-e866 |
artikel |
13 |
25 mm Hg versus 35 mm Hg elastic compression stockings to prevent post-thrombotic syndrome after deep vein thrombosis (CELEST): a randomised, double-blind, non-inferiority trial
|
Galanaud, Jean-Philippe |
|
|
9 |
12 |
p. e886-e896 |
artikel |
14 |
Patient-reported outcomes: important data in early trials of novel therapies
|
Jim, Heather |
|
|
9 |
12 |
p. e866-e868 |
artikel |
15 |
Regional empowerment through decentralised governance under a centralised regulatory system facilitates the development of cellular therapy in China
|
Li, Xiaolei |
|
|
9 |
12 |
p. e942-e954 |
artikel |
16 |
Second primary malignancies in patients with haematological cancers treated with lenalidomide: a systematic review and meta-analysis
|
Saleem, Kainat |
|
|
9 |
12 |
p. e906-e918 |
artikel |